nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—CYP3A4—bone cancer	0.71	1	CbGaD
Nortriptyline—Azatadine—CYP3A4—bone cancer	0.00145	0.153	CrCbGaD
Nortriptyline—Clomipramine—GSTP1—bone cancer	0.00138	0.145	CrCbGaD
Nortriptyline—Irritability—Cisplatin—bone cancer	0.00108	0.00852	CcSEcCtD
Nortriptyline—Petechiae—Methotrexate—bone cancer	0.00104	0.0082	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Cisplatin—bone cancer	0.00103	0.00815	CcSEcCtD
Nortriptyline—Gingivitis—Epirubicin—bone cancer	0.00102	0.00805	CcSEcCtD
Nortriptyline—Olopatadine—CYP3A4—bone cancer	0.00101	0.106	CrCbGaD
Nortriptyline—Dermatitis atopic—Doxorubicin—bone cancer	0.000997	0.0079	CcSEcCtD
Nortriptyline—Petechiae—Epirubicin—bone cancer	0.000969	0.00768	CcSEcCtD
Nortriptyline—Sweating increased—Cisplatin—bone cancer	0.000949	0.00752	CcSEcCtD
Nortriptyline—Gingivitis—Doxorubicin—bone cancer	0.00094	0.00745	CcSEcCtD
Nortriptyline—Delirium—Epirubicin—bone cancer	0.000927	0.00734	CcSEcCtD
Nortriptyline—Pancytopenia—Cisplatin—bone cancer	0.000925	0.00733	CcSEcCtD
Nortriptyline—Petechiae—Doxorubicin—bone cancer	0.000897	0.0071	CcSEcCtD
Nortriptyline—Nocturia—Epirubicin—bone cancer	0.00086	0.00681	CcSEcCtD
Nortriptyline—Delirium—Doxorubicin—bone cancer	0.000858	0.00679	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Cisplatin—bone cancer	0.000856	0.00678	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Cisplatin—bone cancer	0.000851	0.00674	CcSEcCtD
Nortriptyline—Myocardial infarction—Cisplatin—bone cancer	0.000851	0.00674	CcSEcCtD
Nortriptyline—Cyclobenzaprine—CYP3A4—bone cancer	0.000848	0.0892	CrCbGaD
Nortriptyline—Stomatitis—Cisplatin—bone cancer	0.000847	0.00671	CcSEcCtD
Nortriptyline—Epinastine—CYP3A4—bone cancer	0.000842	0.0886	CrCbGaD
Nortriptyline—Atrioventricular block—Epirubicin—bone cancer	0.000822	0.00651	CcSEcCtD
Nortriptyline—Coordination abnormal—Epirubicin—bone cancer	0.000812	0.00643	CcSEcCtD
Nortriptyline—Aplastic anaemia—Methotrexate—bone cancer	0.0008	0.00634	CcSEcCtD
Nortriptyline—Ventricular tachycardia—Epirubicin—bone cancer	0.000797	0.00632	CcSEcCtD
Nortriptyline—Nocturia—Doxorubicin—bone cancer	0.000795	0.0063	CcSEcCtD
Nortriptyline—Oxcarbazepine—CYP3A4—bone cancer	0.000776	0.0816	CrCbGaD
Nortriptyline—Gynaecomastia—Methotrexate—bone cancer	0.000762	0.00604	CcSEcCtD
Nortriptyline—Atrioventricular block—Doxorubicin—bone cancer	0.000761	0.00602	CcSEcCtD
Nortriptyline—Coordination abnormal—Doxorubicin—bone cancer	0.000751	0.00595	CcSEcCtD
Nortriptyline—Aplastic anaemia—Epirubicin—bone cancer	0.000749	0.00593	CcSEcCtD
Nortriptyline—Ventricular tachycardia—Doxorubicin—bone cancer	0.000738	0.00584	CcSEcCtD
Nortriptyline—Eye disorder—Cisplatin—bone cancer	0.000729	0.00577	CcSEcCtD
Nortriptyline—Tinnitus—Cisplatin—bone cancer	0.000727	0.00576	CcSEcCtD
Nortriptyline—Flushing—Cisplatin—bone cancer	0.000724	0.00573	CcSEcCtD
Nortriptyline—Arrhythmia—Cisplatin—bone cancer	0.000697	0.00552	CcSEcCtD
Nortriptyline—Aplastic anaemia—Doxorubicin—bone cancer	0.000693	0.00549	CcSEcCtD
Nortriptyline—Alopecia—Cisplatin—bone cancer	0.000689	0.00546	CcSEcCtD
Nortriptyline—Hepatic function abnormal—Epirubicin—bone cancer	0.000662	0.00525	CcSEcCtD
Nortriptyline—Vascular purpura—Epirubicin—bone cancer	0.000647	0.00512	CcSEcCtD
Nortriptyline—Eye pain—Epirubicin—bone cancer	0.000641	0.00508	CcSEcCtD
Nortriptyline—Vision blurred—Cisplatin—bone cancer	0.00064	0.00507	CcSEcCtD
Nortriptyline—Tremor—Cisplatin—bone cancer	0.000636	0.00504	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Methotrexate—bone cancer	0.000631	0.005	CcSEcCtD
Nortriptyline—Ill-defined disorder—Cisplatin—bone cancer	0.00063	0.00499	CcSEcCtD
Nortriptyline—Hot flush—Epirubicin—bone cancer	0.000619	0.0049	CcSEcCtD
Nortriptyline—Menopausal symptoms—Epirubicin—bone cancer	0.000613	0.00486	CcSEcCtD
Nortriptyline—Hepatic function abnormal—Doxorubicin—bone cancer	0.000613	0.00485	CcSEcCtD
Nortriptyline—Malaise—Cisplatin—bone cancer	0.000612	0.00485	CcSEcCtD
Nortriptyline—Leukopenia—Cisplatin—bone cancer	0.000608	0.00481	CcSEcCtD
Nortriptyline—Purpura—Epirubicin—bone cancer	0.000601	0.00476	CcSEcCtD
Nortriptyline—Vascular purpura—Doxorubicin—bone cancer	0.000599	0.00474	CcSEcCtD
Nortriptyline—Eye pain—Doxorubicin—bone cancer	0.000593	0.0047	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Epirubicin—bone cancer	0.000591	0.00468	CcSEcCtD
Nortriptyline—Irritability—Methotrexate—bone cancer	0.00059	0.00468	CcSEcCtD
Nortriptyline—Convulsion—Cisplatin—bone cancer	0.000588	0.00466	CcSEcCtD
Nortriptyline—Ataxia—Methotrexate—bone cancer	0.000582	0.00461	CcSEcCtD
Nortriptyline—Anxiety—Cisplatin—bone cancer	0.000576	0.00456	CcSEcCtD
Nortriptyline—Hot flush—Doxorubicin—bone cancer	0.000572	0.00453	CcSEcCtD
Nortriptyline—Discomfort—Cisplatin—bone cancer	0.000571	0.00452	CcSEcCtD
Nortriptyline—Menopausal symptoms—Doxorubicin—bone cancer	0.000568	0.0045	CcSEcCtD
Nortriptyline—Purpura—Doxorubicin—bone cancer	0.000556	0.0044	CcSEcCtD
Nortriptyline—Oedema—Cisplatin—bone cancer	0.000554	0.00439	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Doxorubicin—bone cancer	0.000547	0.00433	CcSEcCtD
Nortriptyline—Ataxia—Epirubicin—bone cancer	0.000544	0.00431	CcSEcCtD
Nortriptyline—Thrombocytopenia—Cisplatin—bone cancer	0.000542	0.0043	CcSEcCtD
Nortriptyline—Tachycardia—Cisplatin—bone cancer	0.000541	0.00428	CcSEcCtD
Nortriptyline—Hyperhidrosis—Cisplatin—bone cancer	0.000536	0.00424	CcSEcCtD
Nortriptyline—Eosinophilia—Methotrexate—bone cancer	0.000529	0.00419	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Epirubicin—bone cancer	0.000529	0.00419	CcSEcCtD
Nortriptyline—Anorexia—Cisplatin—bone cancer	0.000528	0.00418	CcSEcCtD
Nortriptyline—Hypotension—Cisplatin—bone cancer	0.000518	0.0041	CcSEcCtD
Nortriptyline—Pancytopenia—Methotrexate—bone cancer	0.000508	0.00402	CcSEcCtD
Nortriptyline—Ataxia—Doxorubicin—bone cancer	0.000504	0.00399	CcSEcCtD
Nortriptyline—Atomoxetine—CYP3A4—bone cancer	0.000498	0.0524	CrCbGaD
Nortriptyline—Paraesthesia—Cisplatin—bone cancer	0.000497	0.00394	CcSEcCtD
Nortriptyline—Eosinophilia—Epirubicin—bone cancer	0.000495	0.00392	CcSEcCtD
Nortriptyline—Erectile dysfunction—Methotrexate—bone cancer	0.000492	0.0039	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Doxorubicin—bone cancer	0.000489	0.00387	CcSEcCtD
Nortriptyline—Mianserin—CYP3A4—bone cancer	0.000487	0.0512	CrCbGaD
Nortriptyline—Decreased appetite—Cisplatin—bone cancer	0.000482	0.00381	CcSEcCtD
Nortriptyline—Drowsiness—Methotrexate—bone cancer	0.000477	0.00378	CcSEcCtD
Nortriptyline—Pancytopenia—Epirubicin—bone cancer	0.000475	0.00376	CcSEcCtD
Nortriptyline—Stomatitis—Methotrexate—bone cancer	0.000465	0.00368	CcSEcCtD
Nortriptyline—Pollakiuria—Epirubicin—bone cancer	0.000462	0.00366	CcSEcCtD
Nortriptyline—Eosinophilia—Doxorubicin—bone cancer	0.000458	0.00363	CcSEcCtD
Nortriptyline—Sweating—Methotrexate—bone cancer	0.000457	0.00362	CcSEcCtD
Nortriptyline—Feeling abnormal—Cisplatin—bone cancer	0.000456	0.00362	CcSEcCtD
Nortriptyline—Weight increased—Epirubicin—bone cancer	0.000455	0.00361	CcSEcCtD
Nortriptyline—Weight decreased—Epirubicin—bone cancer	0.000453	0.00358	CcSEcCtD
Nortriptyline—Drowsiness—Epirubicin—bone cancer	0.000446	0.00353	CcSEcCtD
Nortriptyline—Clomipramine—CYP3A4—bone cancer	0.000445	0.0469	CrCbGaD
Nortriptyline—Agranulocytosis—Methotrexate—bone cancer	0.000445	0.00352	CcSEcCtD
Nortriptyline—Pancytopenia—Doxorubicin—bone cancer	0.00044	0.00348	CcSEcCtD
Nortriptyline—Body temperature increased—Cisplatin—bone cancer	0.000438	0.00347	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Epirubicin—bone cancer	0.000437	0.00346	CcSEcCtD
Nortriptyline—Stomatitis—Epirubicin—bone cancer	0.000435	0.00344	CcSEcCtD
Nortriptyline—Jaundice—Epirubicin—bone cancer	0.000435	0.00344	CcSEcCtD
Nortriptyline—Hepatitis—Methotrexate—bone cancer	0.000428	0.00339	CcSEcCtD
Nortriptyline—Sweating—Epirubicin—bone cancer	0.000428	0.00339	CcSEcCtD
Nortriptyline—Pollakiuria—Doxorubicin—bone cancer	0.000428	0.00339	CcSEcCtD
Nortriptyline—Weight increased—Doxorubicin—bone cancer	0.000421	0.00334	CcSEcCtD
Nortriptyline—Weight decreased—Doxorubicin—bone cancer	0.000419	0.00332	CcSEcCtD
Nortriptyline—Agranulocytosis—Epirubicin—bone cancer	0.000416	0.0033	CcSEcCtD
Nortriptyline—Drowsiness—Doxorubicin—bone cancer	0.000413	0.00327	CcSEcCtD
Nortriptyline—Trimipramine—CYP3A4—bone cancer	0.00041	0.0431	CrCbGaD
Nortriptyline—Hypersensitivity—Cisplatin—bone cancer	0.000408	0.00323	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Doxorubicin—bone cancer	0.000405	0.0032	CcSEcCtD
Nortriptyline—Stomatitis—Doxorubicin—bone cancer	0.000402	0.00319	CcSEcCtD
Nortriptyline—Jaundice—Doxorubicin—bone cancer	0.000402	0.00319	CcSEcCtD
Nortriptyline—Hepatitis—Epirubicin—bone cancer	0.0004	0.00317	CcSEcCtD
Nortriptyline—Eye disorder—Methotrexate—bone cancer	0.0004	0.00317	CcSEcCtD
Nortriptyline—Tinnitus—Methotrexate—bone cancer	0.000399	0.00316	CcSEcCtD
Nortriptyline—Hypoaesthesia—Epirubicin—bone cancer	0.000398	0.00316	CcSEcCtD
Nortriptyline—Asthenia—Cisplatin—bone cancer	0.000397	0.00315	CcSEcCtD
Nortriptyline—Sweating—Doxorubicin—bone cancer	0.000396	0.00313	CcSEcCtD
Nortriptyline—Oedema peripheral—Epirubicin—bone cancer	0.000394	0.00312	CcSEcCtD
Nortriptyline—Doxepin—CYP3A4—bone cancer	0.000391	0.0411	CrCbGaD
Nortriptyline—Agranulocytosis—Doxorubicin—bone cancer	0.000385	0.00305	CcSEcCtD
Nortriptyline—Diarrhoea—Cisplatin—bone cancer	0.000379	0.003	CcSEcCtD
Nortriptyline—Alopecia—Methotrexate—bone cancer	0.000378	0.00299	CcSEcCtD
Nortriptyline—Eye disorder—Epirubicin—bone cancer	0.000374	0.00296	CcSEcCtD
Nortriptyline—Tinnitus—Epirubicin—bone cancer	0.000373	0.00296	CcSEcCtD
Nortriptyline—Flushing—Epirubicin—bone cancer	0.000372	0.00294	CcSEcCtD
Nortriptyline—Hepatitis—Doxorubicin—bone cancer	0.00037	0.00293	CcSEcCtD
Nortriptyline—Hypoaesthesia—Doxorubicin—bone cancer	0.000369	0.00292	CcSEcCtD
Nortriptyline—Oedema peripheral—Doxorubicin—bone cancer	0.000365	0.00289	CcSEcCtD
Nortriptyline—Dysgeusia—Methotrexate—bone cancer	0.000365	0.00289	CcSEcCtD
Nortriptyline—Desipramine—CYP3A4—bone cancer	0.000358	0.0377	CrCbGaD
Nortriptyline—Arrhythmia—Epirubicin—bone cancer	0.000358	0.00283	CcSEcCtD
Nortriptyline—Alopecia—Epirubicin—bone cancer	0.000354	0.0028	CcSEcCtD
Nortriptyline—Vomiting—Cisplatin—bone cancer	0.000352	0.00279	CcSEcCtD
Nortriptyline—Vision blurred—Methotrexate—bone cancer	0.000351	0.00278	CcSEcCtD
Nortriptyline—Rash—Cisplatin—bone cancer	0.000349	0.00277	CcSEcCtD
Nortriptyline—Dermatitis—Cisplatin—bone cancer	0.000349	0.00276	CcSEcCtD
Nortriptyline—Eye disorder—Doxorubicin—bone cancer	0.000346	0.00274	CcSEcCtD
Nortriptyline—Ill-defined disorder—Methotrexate—bone cancer	0.000346	0.00274	CcSEcCtD
Nortriptyline—Tinnitus—Doxorubicin—bone cancer	0.000345	0.00274	CcSEcCtD
Nortriptyline—Flushing—Doxorubicin—bone cancer	0.000344	0.00272	CcSEcCtD
Nortriptyline—Tension—Epirubicin—bone cancer	0.000342	0.00271	CcSEcCtD
Nortriptyline—Dysgeusia—Epirubicin—bone cancer	0.000341	0.0027	CcSEcCtD
Nortriptyline—Nervousness—Epirubicin—bone cancer	0.000339	0.00268	CcSEcCtD
Nortriptyline—Malaise—Methotrexate—bone cancer	0.000336	0.00266	CcSEcCtD
Nortriptyline—Leukopenia—Methotrexate—bone cancer	0.000333	0.00264	CcSEcCtD
Nortriptyline—Arrhythmia—Doxorubicin—bone cancer	0.000331	0.00262	CcSEcCtD
Nortriptyline—Nausea—Cisplatin—bone cancer	0.000329	0.00261	CcSEcCtD
Nortriptyline—Vision blurred—Epirubicin—bone cancer	0.000329	0.0026	CcSEcCtD
Nortriptyline—Alopecia—Doxorubicin—bone cancer	0.000327	0.00259	CcSEcCtD
Nortriptyline—Ill-defined disorder—Epirubicin—bone cancer	0.000323	0.00256	CcSEcCtD
Nortriptyline—Convulsion—Methotrexate—bone cancer	0.000323	0.00256	CcSEcCtD
Nortriptyline—Agitation—Epirubicin—bone cancer	0.00032	0.00254	CcSEcCtD
Nortriptyline—Tension—Doxorubicin—bone cancer	0.000316	0.00251	CcSEcCtD
Nortriptyline—Dysgeusia—Doxorubicin—bone cancer	0.000316	0.0025	CcSEcCtD
Nortriptyline—Malaise—Epirubicin—bone cancer	0.000314	0.00249	CcSEcCtD
Nortriptyline—Discomfort—Methotrexate—bone cancer	0.000313	0.00248	CcSEcCtD
Nortriptyline—Nervousness—Doxorubicin—bone cancer	0.000313	0.00248	CcSEcCtD
Nortriptyline—Syncope—Epirubicin—bone cancer	0.000313	0.00248	CcSEcCtD
Nortriptyline—Leukopenia—Epirubicin—bone cancer	0.000312	0.00247	CcSEcCtD
Nortriptyline—Palpitations—Epirubicin—bone cancer	0.000308	0.00244	CcSEcCtD
Nortriptyline—Confusional state—Methotrexate—bone cancer	0.000307	0.00243	CcSEcCtD
Nortriptyline—Loss of consciousness—Epirubicin—bone cancer	0.000306	0.00243	CcSEcCtD
Nortriptyline—Vision blurred—Doxorubicin—bone cancer	0.000304	0.00241	CcSEcCtD
Nortriptyline—Imipramine—CYP3A4—bone cancer	0.000304	0.032	CrCbGaD
Nortriptyline—Amitriptyline—CYP3A4—bone cancer	0.000302	0.0318	CrCbGaD
Nortriptyline—Convulsion—Epirubicin—bone cancer	0.000302	0.00239	CcSEcCtD
Nortriptyline—Hypertension—Epirubicin—bone cancer	0.000301	0.00238	CcSEcCtD
Nortriptyline—Ill-defined disorder—Doxorubicin—bone cancer	0.000299	0.00237	CcSEcCtD
Nortriptyline—Thrombocytopenia—Methotrexate—bone cancer	0.000298	0.00236	CcSEcCtD
Nortriptyline—Agitation—Doxorubicin—bone cancer	0.000296	0.00235	CcSEcCtD
Nortriptyline—Anxiety—Epirubicin—bone cancer	0.000296	0.00234	CcSEcCtD
Nortriptyline—Hyperhidrosis—Methotrexate—bone cancer	0.000294	0.00233	CcSEcCtD
Nortriptyline—Discomfort—Epirubicin—bone cancer	0.000293	0.00232	CcSEcCtD
Nortriptyline—Malaise—Doxorubicin—bone cancer	0.000291	0.0023	CcSEcCtD
Nortriptyline—Dry mouth—Epirubicin—bone cancer	0.00029	0.0023	CcSEcCtD
Nortriptyline—Anorexia—Methotrexate—bone cancer	0.00029	0.0023	CcSEcCtD
Nortriptyline—Syncope—Doxorubicin—bone cancer	0.000289	0.00229	CcSEcCtD
Nortriptyline—Leukopenia—Doxorubicin—bone cancer	0.000289	0.00229	CcSEcCtD
Nortriptyline—Confusional state—Epirubicin—bone cancer	0.000287	0.00227	CcSEcCtD
Nortriptyline—Palpitations—Doxorubicin—bone cancer	0.000285	0.00226	CcSEcCtD
Nortriptyline—Oedema—Epirubicin—bone cancer	0.000284	0.00225	CcSEcCtD
Nortriptyline—Hypotension—Methotrexate—bone cancer	0.000284	0.00225	CcSEcCtD
Nortriptyline—Loss of consciousness—Doxorubicin—bone cancer	0.000283	0.00225	CcSEcCtD
Nortriptyline—Shock—Epirubicin—bone cancer	0.00028	0.00222	CcSEcCtD
Nortriptyline—Convulsion—Doxorubicin—bone cancer	0.000279	0.00221	CcSEcCtD
Nortriptyline—Thrombocytopenia—Epirubicin—bone cancer	0.000279	0.00221	CcSEcCtD
Nortriptyline—Hypertension—Doxorubicin—bone cancer	0.000278	0.00221	CcSEcCtD
Nortriptyline—Tachycardia—Epirubicin—bone cancer	0.000278	0.0022	CcSEcCtD
Nortriptyline—Hyperhidrosis—Epirubicin—bone cancer	0.000275	0.00218	CcSEcCtD
Nortriptyline—Insomnia—Methotrexate—bone cancer	0.000275	0.00218	CcSEcCtD
Nortriptyline—Anxiety—Doxorubicin—bone cancer	0.000274	0.00217	CcSEcCtD
Nortriptyline—Paraesthesia—Methotrexate—bone cancer	0.000273	0.00216	CcSEcCtD
Nortriptyline—Discomfort—Doxorubicin—bone cancer	0.000271	0.00215	CcSEcCtD
Nortriptyline—Anorexia—Epirubicin—bone cancer	0.000271	0.00215	CcSEcCtD
Nortriptyline—Somnolence—Methotrexate—bone cancer	0.00027	0.00214	CcSEcCtD
Nortriptyline—Dry mouth—Doxorubicin—bone cancer	0.000269	0.00213	CcSEcCtD
Nortriptyline—Dyspepsia—Methotrexate—bone cancer	0.000268	0.00212	CcSEcCtD
Nortriptyline—Hypotension—Epirubicin—bone cancer	0.000266	0.00211	CcSEcCtD
Nortriptyline—Confusional state—Doxorubicin—bone cancer	0.000265	0.0021	CcSEcCtD
Nortriptyline—Decreased appetite—Methotrexate—bone cancer	0.000264	0.00209	CcSEcCtD
Nortriptyline—Oedema—Doxorubicin—bone cancer	0.000263	0.00208	CcSEcCtD
Nortriptyline—Fatigue—Methotrexate—bone cancer	0.000262	0.00208	CcSEcCtD
Nortriptyline—Shock—Doxorubicin—bone cancer	0.000259	0.00205	CcSEcCtD
Nortriptyline—Thrombocytopenia—Doxorubicin—bone cancer	0.000258	0.00204	CcSEcCtD
Nortriptyline—Insomnia—Epirubicin—bone cancer	0.000257	0.00204	CcSEcCtD
Nortriptyline—Tachycardia—Doxorubicin—bone cancer	0.000257	0.00203	CcSEcCtD
Nortriptyline—Paraesthesia—Epirubicin—bone cancer	0.000255	0.00202	CcSEcCtD
Nortriptyline—Hyperhidrosis—Doxorubicin—bone cancer	0.000254	0.00202	CcSEcCtD
Nortriptyline—Somnolence—Epirubicin—bone cancer	0.000253	0.002	CcSEcCtD
Nortriptyline—Anorexia—Doxorubicin—bone cancer	0.000251	0.00199	CcSEcCtD
Nortriptyline—Feeling abnormal—Methotrexate—bone cancer	0.00025	0.00198	CcSEcCtD
Nortriptyline—Dyspepsia—Epirubicin—bone cancer	0.00025	0.00198	CcSEcCtD
Nortriptyline—Decreased appetite—Epirubicin—bone cancer	0.000247	0.00196	CcSEcCtD
Nortriptyline—Hypotension—Doxorubicin—bone cancer	0.000246	0.00195	CcSEcCtD
Nortriptyline—Fatigue—Epirubicin—bone cancer	0.000245	0.00194	CcSEcCtD
Nortriptyline—Constipation—Epirubicin—bone cancer	0.000243	0.00193	CcSEcCtD
Nortriptyline—Urticaria—Methotrexate—bone cancer	0.000241	0.00191	CcSEcCtD
Nortriptyline—Body temperature increased—Methotrexate—bone cancer	0.00024	0.0019	CcSEcCtD
Nortriptyline—Abdominal pain—Methotrexate—bone cancer	0.00024	0.0019	CcSEcCtD
Nortriptyline—Insomnia—Doxorubicin—bone cancer	0.000238	0.00189	CcSEcCtD
Nortriptyline—Paraesthesia—Doxorubicin—bone cancer	0.000236	0.00187	CcSEcCtD
Nortriptyline—Feeling abnormal—Epirubicin—bone cancer	0.000234	0.00186	CcSEcCtD
Nortriptyline—Somnolence—Doxorubicin—bone cancer	0.000234	0.00185	CcSEcCtD
Nortriptyline—Dyspepsia—Doxorubicin—bone cancer	0.000232	0.00184	CcSEcCtD
Nortriptyline—Decreased appetite—Doxorubicin—bone cancer	0.000229	0.00181	CcSEcCtD
Nortriptyline—Fatigue—Doxorubicin—bone cancer	0.000227	0.0018	CcSEcCtD
Nortriptyline—Urticaria—Epirubicin—bone cancer	0.000226	0.00179	CcSEcCtD
Nortriptyline—Constipation—Doxorubicin—bone cancer	0.000225	0.00178	CcSEcCtD
Nortriptyline—Body temperature increased—Epirubicin—bone cancer	0.000225	0.00178	CcSEcCtD
Nortriptyline—Abdominal pain—Epirubicin—bone cancer	0.000225	0.00178	CcSEcCtD
Nortriptyline—Hypersensitivity—Methotrexate—bone cancer	0.000224	0.00177	CcSEcCtD
Nortriptyline—Asthenia—Methotrexate—bone cancer	0.000218	0.00173	CcSEcCtD
Nortriptyline—Feeling abnormal—Doxorubicin—bone cancer	0.000217	0.00172	CcSEcCtD
Nortriptyline—Pruritus—Methotrexate—bone cancer	0.000215	0.0017	CcSEcCtD
Nortriptyline—Hypersensitivity—Epirubicin—bone cancer	0.00021	0.00166	CcSEcCtD
Nortriptyline—Urticaria—Doxorubicin—bone cancer	0.000209	0.00166	CcSEcCtD
Nortriptyline—Abdominal pain—Doxorubicin—bone cancer	0.000208	0.00165	CcSEcCtD
Nortriptyline—Body temperature increased—Doxorubicin—bone cancer	0.000208	0.00165	CcSEcCtD
Nortriptyline—Diarrhoea—Methotrexate—bone cancer	0.000208	0.00165	CcSEcCtD
Nortriptyline—Asthenia—Epirubicin—bone cancer	0.000204	0.00162	CcSEcCtD
Nortriptyline—Pruritus—Epirubicin—bone cancer	0.000201	0.00159	CcSEcCtD
Nortriptyline—Dizziness—Methotrexate—bone cancer	0.000201	0.00159	CcSEcCtD
Nortriptyline—Diarrhoea—Epirubicin—bone cancer	0.000195	0.00154	CcSEcCtD
Nortriptyline—Hypersensitivity—Doxorubicin—bone cancer	0.000194	0.00154	CcSEcCtD
Nortriptyline—Vomiting—Methotrexate—bone cancer	0.000193	0.00153	CcSEcCtD
Nortriptyline—Rash—Methotrexate—bone cancer	0.000192	0.00152	CcSEcCtD
Nortriptyline—Dermatitis—Methotrexate—bone cancer	0.000191	0.00152	CcSEcCtD
Nortriptyline—Headache—Methotrexate—bone cancer	0.00019	0.00151	CcSEcCtD
Nortriptyline—Asthenia—Doxorubicin—bone cancer	0.000189	0.0015	CcSEcCtD
Nortriptyline—Dizziness—Epirubicin—bone cancer	0.000188	0.00149	CcSEcCtD
Nortriptyline—Pruritus—Doxorubicin—bone cancer	0.000186	0.00148	CcSEcCtD
Nortriptyline—Vomiting—Epirubicin—bone cancer	0.000181	0.00143	CcSEcCtD
Nortriptyline—Nausea—Methotrexate—bone cancer	0.000181	0.00143	CcSEcCtD
Nortriptyline—Diarrhoea—Doxorubicin—bone cancer	0.00018	0.00143	CcSEcCtD
Nortriptyline—Rash—Epirubicin—bone cancer	0.000179	0.00142	CcSEcCtD
Nortriptyline—Dermatitis—Epirubicin—bone cancer	0.000179	0.00142	CcSEcCtD
Nortriptyline—Headache—Epirubicin—bone cancer	0.000178	0.00141	CcSEcCtD
Nortriptyline—Dizziness—Doxorubicin—bone cancer	0.000174	0.00138	CcSEcCtD
Nortriptyline—Nausea—Epirubicin—bone cancer	0.000169	0.00134	CcSEcCtD
Nortriptyline—Vomiting—Doxorubicin—bone cancer	0.000167	0.00133	CcSEcCtD
Nortriptyline—Rash—Doxorubicin—bone cancer	0.000166	0.00131	CcSEcCtD
Nortriptyline—Dermatitis—Doxorubicin—bone cancer	0.000166	0.00131	CcSEcCtD
Nortriptyline—Headache—Doxorubicin—bone cancer	0.000165	0.00131	CcSEcCtD
Nortriptyline—Nausea—Doxorubicin—bone cancer	0.000156	0.00124	CcSEcCtD
Nortriptyline—CHRM4—Signaling Pathways—IL3—bone cancer	4.51e-05	0.000292	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—GNA11—bone cancer	4.51e-05	0.000292	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—GNA11—bone cancer	4.48e-05	0.00029	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—ATF1—bone cancer	4.43e-05	0.000287	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IL3—bone cancer	4.32e-05	0.00028	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—DHFR—bone cancer	4.28e-05	0.000277	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SMO—bone cancer	4.27e-05	0.000277	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—PLAU—bone cancer	4.25e-05	0.000275	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SMO—bone cancer	4.24e-05	0.000275	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—ATF1—bone cancer	4.16e-05	0.00027	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—NT5C3A—bone cancer	4.11e-05	0.000267	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TGFBR2—bone cancer	4.09e-05	0.000265	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—CYP3A4—bone cancer	4.09e-05	0.000265	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	4.07e-05	0.000264	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SMO—bone cancer	4.06e-05	0.000263	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IL3—bone cancer	4.06e-05	0.000263	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—GNA11—bone cancer	4e-05	0.000259	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—GNA11—bone cancer	3.9e-05	0.000253	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—ENO2—bone cancer	3.88e-05	0.000252	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—GNA11—bone cancer	3.88e-05	0.000252	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—ENO2—bone cancer	3.88e-05	0.000251	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TGFBR2—bone cancer	3.86e-05	0.00025	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—IGF1R—bone cancer	3.85e-05	0.000249	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SMO—bone cancer	3.75e-05	0.000243	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—GNA11—bone cancer	3.72e-05	0.000241	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TGFBR2—bone cancer	3.69e-05	0.000239	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SMO—bone cancer	3.69e-05	0.000239	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SMO—bone cancer	3.68e-05	0.000238	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SMO—bone cancer	3.67e-05	0.000238	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SMO—bone cancer	3.65e-05	0.000237	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—IGF1R—bone cancer	3.63e-05	0.000235	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—ATF1—bone cancer	3.63e-05	0.000235	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—CYP3A4—bone cancer	3.62e-05	0.000235	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SMO—bone cancer	3.62e-05	0.000235	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SMO—bone cancer	3.61e-05	0.000234	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—ATF1—bone cancer	3.61e-05	0.000234	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—DHFR—bone cancer	3.6e-05	0.000234	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—DHFR—bone cancer	3.6e-05	0.000233	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IL3—bone cancer	3.54e-05	0.000229	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IL3—bone cancer	3.52e-05	0.000228	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—GSTP1—bone cancer	3.49e-05	0.000227	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—IGF1R—bone cancer	3.47e-05	0.000225	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TGFBR2—bone cancer	3.47e-05	0.000225	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—ATF1—bone cancer	3.46e-05	0.000224	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—GNA11—bone cancer	3.43e-05	0.000222	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—GNA11—bone cancer	3.37e-05	0.000219	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IL3—bone cancer	3.37e-05	0.000218	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—GNA11—bone cancer	3.37e-05	0.000218	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—GNA11—bone cancer	3.36e-05	0.000218	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—GNA11—bone cancer	3.36e-05	0.000218	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—GNA11—bone cancer	3.35e-05	0.000217	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—GNA11—bone cancer	3.34e-05	0.000217	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—ENO2—bone cancer	3.34e-05	0.000216	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—GNA11—bone cancer	3.31e-05	0.000215	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—GNA11—bone cancer	3.3e-05	0.000214	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—IGF1R—bone cancer	3.27e-05	0.000212	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—ATF1—bone cancer	3.19e-05	0.000207	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—ATF1—bone cancer	3.13e-05	0.000203	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—ATF1—bone cancer	3.13e-05	0.000203	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—ATF1—bone cancer	3.12e-05	0.000202	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—ATF1—bone cancer	3.11e-05	0.000201	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IL3—bone cancer	3.11e-05	0.000201	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—GSTP1—bone cancer	3.1e-05	0.000201	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—DHFR—bone cancer	3.1e-05	0.000201	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—ATF1—bone cancer	3.08e-05	0.0002	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—ATF1—bone cancer	3.07e-05	0.000199	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IL3—bone cancer	3.06e-05	0.000198	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—CYP3A4—bone cancer	3.05e-05	0.000198	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IL3—bone cancer	3.05e-05	0.000198	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—CYP3A4—bone cancer	3.05e-05	0.000198	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IL3—bone cancer	3.04e-05	0.000197	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IL3—bone cancer	3.03e-05	0.000196	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TGFBR2—bone cancer	3.03e-05	0.000196	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TGFBR2—bone cancer	3.01e-05	0.000195	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IL3—bone cancer	3e-05	0.000195	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ENO2—bone cancer	3e-05	0.000194	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IL3—bone cancer	2.99e-05	0.000194	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GNA11—bone cancer	2.89e-05	0.000188	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	2.88e-05	0.000187	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—IGF1R—bone cancer	2.85e-05	0.000185	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—IGF1R—bone cancer	2.83e-05	0.000184	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—KIT—bone cancer	2.79e-05	0.000181	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—DHFR—bone cancer	2.78e-05	0.00018	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ENO2—bone cancer	2.76e-05	0.000179	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ENO2—bone cancer	2.73e-05	0.000177	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—IGF1R—bone cancer	2.71e-05	0.000176	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TGFBR2—bone cancer	2.66e-05	0.000172	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—KIT—bone cancer	2.63e-05	0.000171	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CYP3A4—bone cancer	2.62e-05	0.00017	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—BRAF—bone cancer	2.62e-05	0.00017	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TGFBR2—bone cancer	2.61e-05	0.000169	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—GSTP1—bone cancer	2.61e-05	0.000169	CbGpPWpGaD
Nortriptyline—ALB—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.61e-05	0.000169	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TGFBR2—bone cancer	2.61e-05	0.000169	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—GSTP1—bone cancer	2.61e-05	0.000169	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TGFBR2—bone cancer	2.6e-05	0.000169	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GNA11—bone cancer	2.6e-05	0.000168	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TGFBR2—bone cancer	2.59e-05	0.000168	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TGFBR2—bone cancer	2.57e-05	0.000166	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	2.56e-05	0.000166	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—DHFR—bone cancer	2.56e-05	0.000166	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—EGFR—bone cancer	2.54e-05	0.000165	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—DHFR—bone cancer	2.54e-05	0.000164	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—KIT—bone cancer	2.52e-05	0.000163	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—IGF1R—bone cancer	2.5e-05	0.000162	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—BRAF—bone cancer	2.47e-05	0.00016	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—IGF1R—bone cancer	2.46e-05	0.000159	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—IGF1R—bone cancer	2.45e-05	0.000159	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—IGF1R—bone cancer	2.45e-05	0.000159	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—IGF1R—bone cancer	2.44e-05	0.000158	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—IGF1R—bone cancer	2.41e-05	0.000157	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—IGF1R—bone cancer	2.41e-05	0.000156	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—EGFR—bone cancer	2.4e-05	0.000155	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GNA11—bone cancer	2.39e-05	0.000155	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GNA11—bone cancer	2.37e-05	0.000154	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—KIT—bone cancer	2.37e-05	0.000154	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—BRAF—bone cancer	2.37e-05	0.000154	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CYP3A4—bone cancer	2.36e-05	0.000153	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.34e-05	0.000152	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ENO2—bone cancer	2.34e-05	0.000151	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—EGFR—bone cancer	2.3e-05	0.000149	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GSTP1—bone cancer	2.24e-05	0.000146	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—BRAF—bone cancer	2.23e-05	0.000144	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MDM2—bone cancer	2.2e-05	0.000142	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CYP3A4—bone cancer	2.17e-05	0.00014	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—DHFR—bone cancer	2.17e-05	0.00014	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—EGFR—bone cancer	2.16e-05	0.00014	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CYP3A4—bone cancer	2.15e-05	0.000139	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.14e-05	0.000139	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MDM2—bone cancer	2.07e-05	0.000134	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—KIT—bone cancer	2.06e-05	0.000134	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—KIT—bone cancer	2.05e-05	0.000133	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GNA11—bone cancer	2.02e-05	0.000131	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GSTP1—bone cancer	2.02e-05	0.000131	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MDM2—bone cancer	1.98e-05	0.000129	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—KIT—bone cancer	1.97e-05	0.000127	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—BRAF—bone cancer	1.94e-05	0.000126	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—BRAF—bone cancer	1.93e-05	0.000125	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—JUN—bone cancer	1.91e-05	0.000124	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—EGFR—bone cancer	1.88e-05	0.000122	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—EGFR—bone cancer	1.87e-05	0.000121	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MDM2—bone cancer	1.87e-05	0.000121	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MMP9—bone cancer	1.86e-05	0.00012	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GSTP1—bone cancer	1.85e-05	0.00012	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.85e-05	0.00012	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GSTP1—bone cancer	1.84e-05	0.000119	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CYP3A4—bone cancer	1.84e-05	0.000119	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.83e-05	0.000118	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—KIT—bone cancer	1.81e-05	0.000118	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PTGS2—bone cancer	1.81e-05	0.000117	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ENO2—bone cancer	1.8e-05	0.000117	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—JUN—bone cancer	1.8e-05	0.000117	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.79e-05	0.000116	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—KIT—bone cancer	1.78e-05	0.000116	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—KIT—bone cancer	1.78e-05	0.000115	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—KIT—bone cancer	1.77e-05	0.000115	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—KIT—bone cancer	1.77e-05	0.000115	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MMP9—bone cancer	1.75e-05	0.000114	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—KIT—bone cancer	1.75e-05	0.000114	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—KIT—bone cancer	1.75e-05	0.000113	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—JUN—bone cancer	1.72e-05	0.000112	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TP53—bone cancer	1.71e-05	0.000111	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—BRAF—bone cancer	1.7e-05	0.00011	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MMP9—bone cancer	1.68e-05	0.000109	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—BRAF—bone cancer	1.68e-05	0.000109	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—BRAF—bone cancer	1.67e-05	0.000108	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—DHFR—bone cancer	1.67e-05	0.000108	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—BRAF—bone cancer	1.67e-05	0.000108	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—BRAF—bone cancer	1.66e-05	0.000108	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—EGFR—bone cancer	1.65e-05	0.000107	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—BRAF—bone cancer	1.65e-05	0.000107	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.64e-05	0.000106	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MDM2—bone cancer	1.63e-05	0.000105	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—EGFR—bone cancer	1.63e-05	0.000105	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—JUN—bone cancer	1.62e-05	0.000105	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—EGFR—bone cancer	1.62e-05	0.000105	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MDM2—bone cancer	1.62e-05	0.000105	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—EGFR—bone cancer	1.62e-05	0.000105	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—EGFR—bone cancer	1.61e-05	0.000104	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PTGS2—bone cancer	1.61e-05	0.000104	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—EGFR—bone cancer	1.6e-05	0.000103	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.59e-05	0.000103	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MMP9—bone cancer	1.58e-05	0.000102	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GSTP1—bone cancer	1.57e-05	0.000102	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GNA11—bone cancer	1.56e-05	0.000101	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MDM2—bone cancer	1.55e-05	0.0001	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—EGFR—bone cancer	1.5e-05	9.73e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MDM2—bone cancer	1.43e-05	9.26e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—EGFR—bone cancer	1.42e-05	9.18e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—JUN—bone cancer	1.41e-05	9.16e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—JUN—bone cancer	1.41e-05	9.12e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MDM2—bone cancer	1.4e-05	9.11e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MDM2—bone cancer	1.4e-05	9.09e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MDM2—bone cancer	1.4e-05	9.06e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MDM2—bone cancer	1.39e-05	9.03e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MDM2—bone cancer	1.38e-05	8.94e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MDM2—bone cancer	1.38e-05	8.92e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MMP9—bone cancer	1.38e-05	8.91e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MMP9—bone cancer	1.37e-05	8.87e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—EGFR—bone cancer	1.36e-05	8.79e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTGS2—bone cancer	1.35e-05	8.77e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTGS2—bone cancer	1.35e-05	8.75e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—JUN—bone cancer	1.35e-05	8.73e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MMP9—bone cancer	1.31e-05	8.49e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—EGFR—bone cancer	1.28e-05	8.27e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TP53—bone cancer	1.26e-05	8.17e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—JUN—bone cancer	1.24e-05	8.05e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—JUN—bone cancer	1.22e-05	7.92e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—JUN—bone cancer	1.22e-05	7.9e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—JUN—bone cancer	1.21e-05	7.87e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GSTP1—bone cancer	1.21e-05	7.86e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—JUN—bone cancer	1.21e-05	7.85e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MMP9—bone cancer	1.21e-05	7.83e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—JUN—bone cancer	1.2e-05	7.77e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—JUN—bone cancer	1.2e-05	7.75e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—bone cancer	1.19e-05	7.71e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MMP9—bone cancer	1.19e-05	7.7e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MMP9—bone cancer	1.19e-05	7.69e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MMP9—bone cancer	1.18e-05	7.66e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MMP9—bone cancer	1.18e-05	7.64e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MMP9—bone cancer	1.17e-05	7.56e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MMP9—bone cancer	1.16e-05	7.54e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—bone cancer	1.16e-05	7.54e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—bone cancer	1.14e-05	7.38e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EGFR—bone cancer	1.11e-05	7.2e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EGFR—bone cancer	1.11e-05	7.17e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—bone cancer	1.07e-05	6.94e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EGFR—bone cancer	1.06e-05	6.86e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—bone cancer	1.04e-05	6.77e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EGFR—bone cancer	9.76e-06	6.33e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—bone cancer	9.6e-06	6.22e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EGFR—bone cancer	9.6e-06	6.22e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EGFR—bone cancer	9.58e-06	6.21e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EGFR—bone cancer	9.55e-06	6.19e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—bone cancer	9.52e-06	6.17e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EGFR—bone cancer	9.52e-06	6.17e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EGFR—bone cancer	9.43e-06	6.11e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EGFR—bone cancer	9.4e-06	6.09e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—bone cancer	9.33e-06	6.05e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—bone cancer	9.28e-06	6.02e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—bone cancer	8.89e-06	5.76e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—bone cancer	8.19e-06	5.31e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—bone cancer	8.13e-06	5.27e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—bone cancer	8.06e-06	5.23e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—bone cancer	8.04e-06	5.21e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—bone cancer	8.02e-06	5.2e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—bone cancer	7.99e-06	5.18e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—bone cancer	7.91e-06	5.13e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—bone cancer	7.89e-06	5.12e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—bone cancer	6.28e-06	4.07e-05	CbGpPWpGaD
